Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial
Éric Baudin, Thomas Walter, A. Beron, D. Smith, Julien Hadoux, Choaib Lachachi and 14 more
- Rank
- 88 of 3,616
- Percentile
- top 2.5%
- Where
- Annals of Oncology, 2022
- Citations
- 45
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.